GTx (GTXI)

Create an Alert
7.13 +0.12  +1.71%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

GTx Revenue Quarterly:

0.00 for March 31, 2013
View Full Chart

GTx Revenue Quarterly Chart

    GTx Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.00
    Dec. 31, 2012 0.00
    Sept. 30, 2012 0.00
    June 30, 2012 1.639M
    March 31, 2012 0.00
    Dec. 31, 2011 0.00
    Sept. 30, 2011 0.00
    June 30, 2011 1.645M
    March 31, 2011 9.295M
    Dec. 31, 2010 1.805M
    Sept. 30, 2010 1.296M
    June 30, 2010 0.935M
    March 31, 2010 56.58M
    Dec. 31, 2009 3.677M
    Sept. 30, 2009 3.60M
    June 30, 2009 3.822M
    March 31, 2009 3.631M
    Dec. 31, 2008 2.998M
    Sept. 30, 2008 3.049M
    June 30, 2008 3.008M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    GTXI Revenue Quarterly Benchmarks

    Companies
    Array BioPharma 9.955M
    Achillion Pharmaceuticals 0.00
    Anacor Pharmaceuticals 3.288M

    GTXI Revenue Quarterly Rankings

    Overall 50th percentile
    8312 of 16773
    Sector 40th percentile
    833 of 1408 in Healthcare
    Industry 45th percentile
    248 of 453 in Biotechnology

    GTXI Revenue Quarterly Range, Past 5 Years

    Minimum 0.000 Sep 2011
    Maximum 56.58M Mar 2010
    Average 4.849M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');